Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
[Radium 223 in castration resistant prostate cancer.]
PubMed
Details
Locations
Year:
2018
Type:
article
Source:
PubMed
Authors:
Ana Loizaga-Iriarte,
Isabel Camargo Ibargarai,
Nerea Senarriaga-Ruiz de la Illa,
Isabel Lacasa-Viscasillas,
Miguel Unda-Urzaiz
Institution:
Hospital de Basurto
Language:
Spanish
Topic:
Prostate Cancer Treatment and Research
Subfield:
Cancer Research
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
radium-223,
castration-resistant prostate cancer,
bone metastasis,
alpha therapy,
ALSYMPCA trial,
overall survival,
docetaxel,
skeletal-related events,
PSA response,
bone turnover markers,
adverse effects
show all 11
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2899614651
FWCI:
0.069
Cites:
Cited by:
1
Related to:
10